Trace quantification of 1-octacosanol and 1-triacontanol and their main metabolites in plasma by liquid-liquid extraction coupled with gas chromatography-mass spectrometry

被引:14
作者
Haim, Daniela [1 ]
Berrios, Miriam [2 ]
Valenzuela, Alfonso [3 ]
Videla, Luis A. [1 ]
机构
[1] Univ Chile, Mol & Clin Pharmacol Program, Inst Biomed Sci, Fac Med, Santiago 7, Chile
[2] Harting SA, R&D Lab, Santiago, Chile
[3] Univ Chile, Lab Lipids & Antioxidants, Inst Nutr & Food Technol, Santiago 7, Chile
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2009年 / 877卷 / 32期
关键词
1-Octacosanol; 1-Triacontanol; GC-MS; RANDOMIZED CONTROLLED-TRIAL; RAT PLASMA; POLICOSANOL; HYPERCHOLESTEROLEMIA; TOLERABILITY; EFFICACY;
D O I
10.1016/j.jchromb.2009.10.034
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A method for the simultaneous determination of 1-octacosanol and 1-triacontanol and their main metabolites in rat plasma was developed. The procedure involved ethanolic NaOH saponification of the sample, acidification, liquid-liquid extraction, and derivatization of the analytes to its trimethylsilylether/ester, followed analysis by gas chromatography-mass Spectrometry (GC-MS) in selected ion monitoring(SIM) mode. Quantification was performed by the internal standard method using betulin. The method had a good linearity over the range 8.4-540ng/ml (r >= 0.998) and showed an excellent intra-day (R.S.D. = 0.59-3.06%) and inter-day (R.S.D. = 2.99-5.22%) precision according to the acceptance criteria. The detection limits ranged between 1.32 and 3.47 ng/ml. The method was applied successfully to study the total plasmatic concentration of 1-octacosanol, octacosanoic acid, 1-triacontanol, and triacontanoic acid, after an oral dose of policosanols mixture, using plasma samples of 100 Id. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:4154 / 4158
页数:5
相关论文
共 16 条
[1]   Protective effect of policosanol on atherosclerotic lesions in rabbits with exogenous hypercholesterolemia [J].
Arruzazabala, ML ;
Noa, M ;
Menéndez, R ;
Más, R ;
Carbajal, D ;
Valdés, S ;
Molina, V .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2000, 33 (07) :835-840
[2]   Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia - A randomized controlled trial [J].
Berthold, HK ;
Unverdorben, S ;
Degenhardt, R ;
Bulitta, M ;
Gouni-Berthold, I .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (19) :2262-2269
[3]  
Castaño G, 2001, INT J CLIN PHARM RES, V21, P43
[4]  
Crespo N, 1999, INT J CLIN PHARM RES, V19, P117
[5]   Trace determination of 1-octacosanol in rat plasma by solid-phase extraction with Tenax GC and capillary gas chromatography [J].
Delange, DM ;
Bravo, LG .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2001, 762 (01) :43-49
[6]   Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial [J].
Dulin, Michael F. ;
Hatcher, Lauren F. ;
Sasser, Howell C. ;
Barringer, Thomas A. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 84 (06) :1543-1548
[7]   Policosanol: Results of a postmarketing surveillance study of 27,879 patients [J].
Fernandez, L ;
Mas, R ;
Illnait, J ;
Fernandez, JC .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (10) :717-722
[8]   Analytical procedure for the determination of 1-octacosanol in plasma by solvent extraction and capillary gas chromatography [J].
GonzalezBravo, L ;
MagranerHernandez, J ;
AcostaGonzalez, PC ;
PerezSouto, N .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1996, 682 (02) :359-363
[9]  
Haim D, 2008, AGRO FOOD IND HI TEC, V19, P60
[10]  
HERNANDEZ F, 1992, CURR THER RES CLIN E, V51, P568